DrugPatentWatch Database Preview
Profile for Brazil Patent: 122018015003
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Brazil Patent: 122018015003
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | May 27, 2024 | Novartis Pharms Corp | ENTRESTO | sacubitril; valsartan |
Start Trial | Jul 14, 2023 | Novartis Pharms Corp | ENTRESTO | sacubitril; valsartan |
Start Trial | Jul 14, 2023 | Novartis Pharms Corp | ENTRESTO | sacubitril; valsartan |
Start Trial | Jul 14, 2023 | Novartis Pharms Corp | ENTRESTO | sacubitril; valsartan |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |